InsiderTrades

Form 4 for BYRN Byrna Technologies Inc.

Accepted 2023-10-17 00:00:00 ET · period of report 2022-03-22 · accession 0001437749-23-028444 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-10-17 2023-10-13+ BYRN Ganz Bryan Pres, CEO, Dir P - Purchase $3.19 +17.0K 615.1K +3% +$54.1K
DMI 2023-10-17 2022-12-31 BYRN Ganz Bryan Pres, CEO, Dir J - Other $0.00 -2,600 0 -100% $0
D 2023-10-17 2022-03-23 BYRN Ganz Bryan Pres, CEO, Dir D - Sale to Iss $0.00 -450.0K 450.0K -50% $0
D 2023-10-17 2022-03-23 BYRN Ganz Bryan Pres, CEO, Dir A - Grant $0.00 +450.0K 450.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-10-16 P A 5,000 $3.51 620,148 D By the David Ganz Trust FBO Madelyn Hyland — —
2 Common Common Stock 2023-10-13 P A 12,000 $3.05 615,148 D By the David Ganz Trust FBO Kathryn R. Ganz — — (F1) The shares were purchased in multiple transactions at prices ranging from $2.98 to $3.10. The reported price of $3.0536 represents the volume weighted average price for the reported transaction. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
3 Common Common Stock 2022-12-31 J D 1,300 $0.00 0 I — — (F3) The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F2) The reporting person served as trustee of each trust, of which certain members of the reporting person's immediate family were beneficiaries. On December 31, 2022, the trusts distributed all shares of the issuer's common stock to the beneficiaries of the trusts. Prior to distribution, the reporting person disclaimed beneficial ownership of the securities held by the trusts except to the extent of his pecuniary interest therein.
4 Common Common Stock 2022-12-31 J D 1,300 $0.00 0 I — — (F3) The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F2) The reporting person served as trustee of each trust, of which certain members of the reporting person's immediate family were beneficiaries. On December 31, 2022, the trusts distributed all shares of the issuer's common stock to the beneficiaries of the trusts. Prior to distribution, the reporting person disclaimed beneficial ownership of the securities held by the trusts except to the extent of his pecuniary interest therein.
5 Derivative Restricted Stock Unit 2022-03-23 D D 450,000 $0.00 450,000 D — · — to 2023-08-31 450,000 Common Stock (F5) Each restricted stock unit represents the right to receive one share of common stock. (F6) The original grant of restricted stock units ("Units") consisted of 300,000 Units with a $20 20-day VWAP performance trigger, 300,000 Units with a $30 20-day VWAP performance trigger ("$30 Trigger"), and 300,000 Units with a $40 20-day VWAP performance trigger ("$40 Trigger"). The Reporting Person was required to remain in service to the Company through August 31, 2023 for any Units to vest. The Reporting Person agreed to an amendment of the original Restricted Stock Unit Agreement, approved by the Board, to provide for cancellation of half the Units, consisting of all Units with a $40 Trigger and 150,000 Units with a $30 Trigger, in exchange for a grant of an equal number of options as described herein.
6 Derivative Stock Option (right to buy) 2022-03-23 A A 450,000 $0.00 450,000 D $9.23 · — to 2023-03-23 450,000 Common Stock (F7) One third of the grant (the "Option Shares") will vest and become exercisable on 3/23/23 (the "Year Anniversary"); the balance of the Option Shares will vest in eight (8) quarterly, consecutive, and equal installments thereafter, beginning on the first calendar day of the fiscal quarter immediately following the Year Anniversary, until all Option Shares are fully vested.